We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Allstate
ALL
$70.1B
| $8.73M | 0.06% |
90,015
-5,753
| -6% | -$565K |
|
227
Estee Lauder
EL
$30.7B
| $8.57M | 0.06% |
45,418
+20,192
| +80% | +$3.61M |
|
228
iShares MSCI Emerging Markets ETF
EEM
$28B
| $8.54M | 0.06% |
213,500
-83,000
| -28% | -$3.11M |
|
229
Newmont
NEM
$96.4B
| $8.49M | 0.06% |
137,578
-8,803
| -6% | -$521K |
|
230
Cigna
CI
$79.6B
| $8.49M | 0.06% |
45,223
-2,840
| -6% | -$539K |
|
231
Ball Corp
BALL
$17.8B
| $8.47M | 0.06% |
121,963
-7,804
| -6% | -$527K |
|
232
Freeport-McMoran
FCX
$88.6B
| $8.34M | 0.06% |
720,991
-26,118
| -3% | -$239K |
|
233
D.R. Horton
DHI
$42.3B
| $8.31M | 0.06% |
149,960
-4,974
| -3% | -$241K |
|
|
GAN
234
DELISTED
GAN Ltd
GAN
| $8.31M | 0.06% |
+326,341
| New | +$6.24M |
|
235
O'Reilly Automotive
ORLY
$75.6B
| $8.29M | 0.06% |
294,930
-18,870
| -6% | -$493K |
|
236
Lithia Motors
LAD
$8.17B
| $8.29M | 0.06% |
54,776
+25,012
| +84% | +$2.86M |
|
|
RDS.A
237
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $8.17M | 0.06% |
250,000
| – | – |
|
238
DuPont de Nemours
DD
$19B
| $8.14M | 0.06% |
122,067
-7,810
| -6% | -$456K |
|
|
WBA
239
DELISTED
Walgreens Boots Alliance
WBA
| $8.06M | 0.06% |
190,118
-8,797
| -4% | -$374K |
|
240
Prologis
PLD
$137B
| $7.99M | 0.06% |
85,658
-5,481
| -6% | -$489K |
|
241
Dollar General
DG
$27.8B
| $7.91M | 0.06% |
41,536
-4,793
| -10% | -$867K |
|
242
Palomar
PLMR
$3.79B
| $7.88M | 0.06% |
91,904
+14,215
| +18% | +$943K |
|
243
Arthur J. Gallagher & Co
AJG
$68.2B
| $7.84M | 0.06% |
80,377
-5,143
| -6% | -$455K |
|
244
Sherwin-Williams
SHW
$87.4B
| $7.64M | 0.05% |
39,654
-2,538
| -6% | -$458K |
|
245
Jack Henry & Associates
JKHY
$11.2B
| $7.43M | 0.05% |
40,363
-2,583
| -6% | -$450K |
|
246
Alexandria Real Estate Equities
ARE
$9.41B
| $7.42M | 0.05% |
45,717
-2,925
| -6% | -$447K |
|
|
BLD
247
DELISTED
TopBuild
BLD
| $7.42M | 0.05% |
65,187
+10,719
| +20% | +$1.07M |
|
248
Generac Holdings
GNRC
$11.5B
| $7.36M | 0.05% |
60,396
+29,057
| +93% | +$3.06M |
|
249
Deere & Co
DE
$173B
| $7.36M | 0.05% |
46,850
-2,998
| -6% | -$434K |
|
250
CALL
ServiceNow
NOW
$114B
| $7.25M | 0.05% |
+89,500
| New | +$6.32M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.